TerrAscend

TerrAscend Secures Multi-Year Cannabis Supply Agreement with PharmHouse  Inc., a Canopy Rivers Joint Venture

TER Profile

  • Sector: Process Industries
  • Industry: Agricultural Commodities/Milling

TerrAscend Corp. produces and sells medical cannabis products. It provides support to patients through its subsidiaries, Solace Health Inc., a licensed producer of medical cannabis, TerraHealth Network Inc., a clinical support program and education platform led by health care professionals and SolaceRx, a proposed drug preparation premises for the compounding of non-cannabis formulations for a variety of institutions. The firm also offers education and support programs to physicians and patients through health care professionals. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.

Recent News

The Next Big Run: Oblong (NYSE: OBLG)

Oblong Inc. is setting up for another massive run after a solid consolidation, you can see in the above chart the similar patterns have been detected in the past and resulted with a huge breakout. This particular stock has 3.57 million share float with high percentage insider ownership, meaning this stock could be moving very […]

Jushi Holdings Inc. Acquires Remaining Equity Interests in Agape Total Health Care Inc, a Pennsylvania Medical Marijuana Dispensary Permit Holder

Jushi Has Now Become the 100% Equity Owner of All of Its Retail and Grower-Processor Subsidiaries in Pennsylvania, Illinois, and Virginia Currently Operates 16 Stores Nationally Holds the Rights to Open an Additional 16 Stores Nationally and Expects to Open 10 to 12 Stores in 2021 BOCA RATON, Fla., Jan. 26, 2021 (GLOBE NEWSWIRE) — Jushi […]

Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full

NYSE | TSX: ACB EDMONTON, AB, Jan. 26, 2021 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The […]

Loading…

Something went wrong. Please refresh the page and/or try again.